Cover -- Table of Contents -- Detailed Table of Contents -- Foreword -- Introduction -- 1: What World Will We Live In? -- 2: Why Think About Ethics? -- 3: A Brave New World of Clones -- 4: Human Cloning: Should Humans be Cloned? -- 5: Stem Cell Research -- 6: GM Foods: What Are They Doing to Our Dinner? -- A History of Biotechnology -- Glossary -- Bibliography -- Further Reading -- Websites -- Index -- Picture Credits -- About the Contributor.
2.3 Adoption of Agricultural Biotechnology Practices2.4 Factors That Bring About Changes in Agricultural Biotechnology; Chapter 3 Application of Agricultural Biotechnology in Crops Production; 3.1 Introduction; 3.2 Crops Genetic Modification; Chapter 4 Agricultural Biotechnology in Beef Cattle; 4.1 Introduction; 4.2 Ways of Improving the Quality of Beef Cattle Genetically; 4.3 Adoption of Biotechnologies in Beef Cattle Production; Chapter 5 Practical Application of Agricultural Biotechnology in Dairy Farming; 5.1 Introduction; 5.2 Classification of Dairy Cattle
There is a long-felt need for an updated comprehensive book on Biotechnology. This book encompasses eighteen chapters covering various aspects of Biotechnology. It is written in a simple, lucid, and illustrative manner. A short reference of source materials, subject index, possible questions and experiments are also listed. The tools and techniques and applications of Biotechnology in different groups of organisms-starting from bacteria to higher organisms-are also covered for the benefit of the students.
About the Book: Modern biotechnology has come into prominence since 1980. It relates to a set of techniques that involve manipulation or change of the genetic inheritance of living organisms including plants. The primary advantage of this technology is that it can target drugs and pesticides to the exact location of the human body or plants where they are needed. The cost of application as well as the side effects can be minimized if this technology is utilized. It is also advantageous in so far as random trials on chemicals to develop drugs and hit and fail methods of conventional plant breeding can be avoided. Economics of Biotechnology deals with the organizational mechanisms to accelerate developments in biotechnology, the patents and IPRs necessary to obtain the requisite R & D and compensate the entrepreneurs, and the emerging markets for products of biotechnology and their pricing. It also deals with the implications of modern biotechnology for biodiversity and biosafety and the enabling and regulatory role of the government in its development. Thus the book makes an attempt to introduce the reader to the economics underlying what promises to be the technology of the 21st century. Contents: Organizational Structure IPRs and Patents Investment and Financing Demand, Cost, and Productivity Market Structure and Pricing Ethics and Environment Government Policy Conclusion
The final essay in a symposium on biotechnology focuses on guiding & controlling the powers of biotechnology in response to concerns about distorting or destroying what is good. The limits to what can be produced biochemically are explored, along with examples of what is considered "good"; the meaning of human nature; & the connection between reason & a body's place in experience or enjoyment. It is contended that what is good for humans involves satisfying both reason & passion. Increased mental power will only be satisfying if it is capable of addressing subtle & complex matters. Improved senses, such as the ability to hear as well as a bat, will not fundamentally change anything for the better. Special attention is given to questions surrounding cloning, stem cells, & genetic selection. An argument for minimal regulation is based on the potential for moral claims to override common benefit, the need for responsible choices guided by intelligent reflection, & respect for the complexity of vital connections that might be inadvertently disrupted. J. Lindroth
Much of the debate about biotechnology and the environment is not so much about the nature and magnitude of the risk, but rather, who should bear the costs if a course of action proves to be in error. Should biotechnology products be readily approved for use, placing the burden of error on the environment? Or should the products be very cautiously screened, placing the bur-den of error on the inventors and users of the product?
Ghosh, P. ; Ghose, T. K.: Bioethanol in India. Recent past and emerging future. Mazumdar-Shaw, K. ; Suryanarayan, S.: Commercialization of a novel fermentation concept. Panda, A. K.: Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli. Chand, S. ; Mishra, P.: Microbial enzymes and their applications? India's contribution. Nath, S.: Molecular mechanisms of energy transduction in cells. Engineering applications and biological implications. Gupta, S. K.: Status of immunodiagnosis and immunocontraceptive vaccines in India. Lohray, B. B.: Medical biotechnology in India
This paper explores the relationship among ideology, media science news use, and three different types of trust (trust in government, trust in science, and trust in regulative institute), as well as their direct and indirect impact on the support of agricultural biotechnology and the support of regulation on genetic modified organisms (GMO). A structural model showed that the public are slightly leaning toward the use of biotechnology; meanwhile they overwhelmingly request the control on GMO. Level of education directly promoted all three types of trusts and had a positive effect on the support of biotechnology and the support of regulation on GMO. Media science news use has both a direct and an indirect positive effect (through trust in scientific process) on support of biotechnology. Among the three different types of trusts, trust on government did not have significant effects on public attitude toward biotechnology. Trust in regulative institutes, associated with more control on GMO, decreased the public's support of biotechnology. Meanwhile, trust in scientific process directly bolstered public's support of biotechnology.